Sartorius Stedim Biotech S.A. (EPA:DIM)
France flag France · Delayed Price · Currency is EUR
170.20
+0.10 (0.06%)
Jul 31, 2026, 1:13 PM CET

Sartorius Stedim Biotech Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Sartorius Stedim Biotech stock has a consensus rating of "Buy" and an average price target of €229.79. The average 1-year stock price forecast is 35.01% higher than the current stock price, while the lowest is €208.00 (+22.21%) and the highest is €262.00 (+53.94%).

Price Target: €229.79 (+35.01%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price€208.00€229.79€227.50€262.00
Change+22.21%+35.01%+33.67%+53.94%

Analyst Ratings

The average analyst rating for Sartorius Stedim Biotech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy577777
Buy466666
Hold511111
Sell000000
Strong Sell000000
Total141414141414

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bernstein
Bernstein
Buy
Maintains
€245.00€230.00
BuyMaintains€245.00€230.00+35.14%Jul 28, 2026
J.P. Morgan
J.P. Morgan
Buy
Maintains
€260.00
BuyMaintains€260.00+52.76%Jul 24, 2026
RBC Capital
RBC Capital
Buy
Maintains
€210.00
BuyMaintains€210.00+23.38%Jul 23, 2026
UBS
UBS
Hold
Maintains
€220.00
HoldMaintains€220.00+29.26%Jul 13, 2026
HSBC
HSBC
Buy
Maintains
€233.00€230.00
BuyMaintains€233.00€230.00+35.14%Jun 3, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.13B
from 2.97B
Increased by 5.46%
Revenue Next Year
3.47B
from 3.13B
Increased by 10.90%
EPS This Year
5.00
from 4.40
Increased by 13.56%
EPS Next Year
5.96
from 5.00
Increased by 19.20%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
2.89B3.49B2.78B2.78B2.97B3.13B
Revenue Growth
51.15%20.98%-20.53%0.16%6.74%5.46%
Gross Profit
1.55B1.82B1.23B1.21B1.35B1.45B
Gross Margin
53.79%52.03%44.46%43.41%45.33%46.38%
Operating Income
920.20M1.05B469.40M396.00M538.10M611.20M
Net Income
414.40M876.10M310.30M175.10M265.60M376.26M
EPS
----4.405.00
EPS Growth
----26.07%13.56%
Forward PE
60.2831.4849.6446.4940.9834.06
Dividend / Share
1.261.440.690.690.690.82
Dividend Growth
-14.29%-52.08%--19.06%
Free Cash Flow
425.14M93.93M81.05M369.80M177.20M420.50M
No. Analysts
-----10
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High3.2B
Avg3.1B
Low3.1B

Revenue Growth

Revenue Growth202620272028
High
6.3%
Avg
5.5%
Low
4.6%

EPS Forecast

EPS202620272028
High5.25
Avg5.00
Low4.54

EPS Growth

EPS Growth202620272028
High
19.3%
Avg
13.6%
Low
3.2%